Attention recruitment agencies: All agency inquiries are vetted through 4DMT’s internal Talent Acquisition team. No unsolicited resumes will be accepted. The 4DMT Talent Acquisition team must expressly engage agencies on any requisition. Agencies contacting hiring managers directly will not be tolerated, and doing so may impact your ability to work with 4DMT in the future.

4DMT is a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. The Company’s lead product candidate 4D-150 is designed to be a backbone therapy forming the foundation of treatment of blinding retinal vascular diseases by providing multi-year sustained delivery of anti-VEGF biologics (aflibercept and anti-VEGF-C) with a single intravitreal injection, which substantially reduces the treatment burden associated with current bolus injections. The Company’s lead indication for 4D-150 is wet age-related macular degeneration and the second indication is diabetic macular edema, which are both in Phase 3 development. The Company’s second product candidate is 4D-710, which is the first known genetic medicine to demonstrate successful delivery and expression of the CFTR transgene in the lungs of people with cystic fibrosis after aerosol delivery.

We are taking genetic medicine to new heights and into new disease areas to overcome challenges not addressed by existing medicines. This incredible challenge drives our relentless and talented team. Our people are the essence of our inspiring, innovative and collaborative environment that encourages individual contributions and provides opportunities for career development. We seek the best in the industry who identify with our mission and our bold and innovative results-driven approach. Our Core Values drive the way we work together:

Dare to Cure
Break Boundaries
Beyond Yourself
Prepare & Execute Relentlessly

Join us in creating the future of genetic medicine.

GENERAL SUMMARY

The Senior Accountant will be responsible for day-to-day accounting operations, monthly close activities, cash management, expense administration, and process improvement initiatives. This role will serve as a key business partner across Finance, Procurement, Human Resources, and Operations to ensure accurate financial reporting, strong internal controls, and scalable processes. The ideal candidate is a detail oriented, hands-on accountant with strong operational accounting experience in a public company or life sciences environment who thrives in a fast-paced, growing organization. This is a hybrid role with a minimum in-office work of once per week.

MAJOR DUTIES & RESPONSIBILITIES

Accounting Operations

Manage daily accounting operations, including processing cash transactions such as internal transfer requests and weekly AP payment runs and other general accounting activities.
Prepare journal entries, account reconciliations, and supporting schedules.
Perform bank reconciliations for operating, payroll, and investment accounts.
Manage the prepaid expense and fixed asset module
Monitor cash activity and support weekly cash forecasting.
Create and maintain Chart of Accounts, departments, and projects in NetSuite
Coordinate and perform the annual fixed asset inventory count

Month-End Close & Balance Sheet Ownership

Own the month-end and quarter-end close process for cash, prepaid expenses, fixed assets, lease accounting, other assets and other accrued liabilities.
Prepare and record journal entries, account reconciliations, and supporting schedules to ensure accurate financial reporting.
Perform monthly bank reconciliations and investigate reconciling items in a timely manner.
Maintain prepaid expense schedules and record monthly amortization entries.
Manage fixed asset accounting, including additions, disposals, depreciation, and reconciliation of the fixed asset subledger.
Administer lease accounting in accordance with ASC 842, including monthly lease entries, amortization schedules, and related balance sheet reconciliations.